calendar
13,708 catalysts · 13,125 approval · 5,000 device 510k · 4,728 grant · 3,057 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
13,708 catalysts · 13,125 approval · 5,000 device 510k · 4,728 grant · 3,057 8k filing · 2,000 device pma · 2,000 device recall
no tagged catalysts yet
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA INC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL
Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR
Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL
Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL
Sponsor: BAJAJ. Form: SOLUTION. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION
Sponsor: STRIDES PHARMA INTL. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: DR REDDYS LABS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: TORRENT. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: AZURITY. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL